How does per-oral endoscopic myotomy compare to Heller myotomy? The Latin American perspective
| Autor: | Michel Kahaleh, Amy Tyberg, Supriya Suresh, Arnon Lambroza, Monica Gaidhane, Felipe Zamarripa, Guadalupe Ma Martínez, Juan C. Carames, Eduardo T. Moura, Galileu F. Farias, Maria G. Porfilio, Jose Nieto, Mario Rey, Fernando Rodriguez Casas, Oscar V. Mondragón Hernández, Romulo Vargas-Rubio, Raul Canadas, Albis Hani, Guillermo Munoz, Bismarck Castillo, Hannah P. Lukashok, Carlos Robles-Medranda, Eduardo G de Moura |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Endoscopy International Open, Vol 08, Iss 10, Pp E1392-E1397 (2020) |
| Druh dokumentu: | article |
| ISSN: | 2364-3722 2196-9736 |
| DOI: | 10.1055/a-1223-1521 |
| Popis: | Background and study aims Both Heller myotomy (HM) and per-oral endoscopic myotomy (POEM) are efficacious therapies for achalasia. The efficacy and safety of POEM vs HM in Latin America and specifically in patients with Chagas disease is unknown. Patients and methods Consecutive patients undergoing either HM or POEM for achalasia were included from nine Latin American centers in a prospective registry over 5 years. Technical success was defined as undergoing a successful myotomy. Clinical success was defined as achieving an Eckardt score |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|